AudioEye Reports Record Third Quarter 2026 Results

AudioEye reported Q3 2026 revenue of $11.0 million, up 7% year over year, and GAAP net income of $1.0 million versus a $0.6 million loss a year earlier; adjusted EBITDA rose 58% to $3.9 million. ARR grew 12% year over year to $43.3 million, while gross margin increased to 83% from 77%. The company raised full-year 2026 adjusted EBITDA guidance to $13.4–$13.6 million, representing about 50% year-over-year growth, and expects Q4 revenue of $11.4–$11.6 million and annualized sequential revenue growth of approximately 20%. AudioEye also authorized up to $15 million in share repurchases and launched two AI products in October.

Analysis

The quality of the quarter is better than the headline growth rate, but the key underwriting question is whether margin gains are durable or mostly cost removal. AI-enabled delivery could structurally lower service costs; however, reduced R&D and sales/marketing make it important to verify that efficiency is not being bought at the expense of product velocity or customer acquisition. The new AI products are a potential moat only if they convert into paid adoption, retention, or faster ARR growth—not on company-reported product performance claims alone.

The buyback is less reassuring than the authorization suggests. The $15 million maximum is large relative to $9.3 million of cash, while term debt is about $16.2 million; execution therefore depends on future cash generation and competes with debt reduction and investment. Treat the authorization as optionality, not a near-term demand floor. Also discount adjusted EBITDA somewhat: litigation costs were a material adjustment, and the company’s nine-month GAAP result remained loss-making despite Q3 profitability.

Near term, the conference call is the catalyst: listen for ARR conversion, customer retention, sales investment, cash-flow details, and actual buyback pacing. Over 1–3 months, delivery of Q4 guidance and sequential ARR progress matter more than annualized quarterly growth language. Over 6–18 months, AI-assisted accessibility could expand the market, but platform-level automation and customers’ in-house tools could commoditize basic audits. The contrarian risk is that investors capitalize efficiency gains as durable operating leverage before recurring growth reaccelerates. No peer ticker is supplied or needed for the trade thesis.

Key Decisions for Investors

• Do not chase the release before the conference call. Consider a starter long in AEYE only if management substantiates recurring-revenue momentum and explains how AI product launches translate into paid adoption; scale only after Q4 guidance is delivered.
• Treat the $15 million repurchase as a ceiling, not a commitment. Verify quarterly operating cash flow, debt repayment, and actual repurchases; slow cash generation alongside buybacks would weaken the capital-return thesis.
• For the next 1–3 months, track ARR growth and customer retention against revenue guidance. A revenue beat driven by non-recurring work, or ARR stalling, would falsify the operating-leverage thesis and argue against adding exposure.
• Reassess after the call if management indicates continued cuts to sales or R&D, weaker customer acquisition, or material litigation cash costs. These would suggest reported margin expansion is less repeatable than adjusted EBITDA implies.